Fisher & Paykel Healthcare logo

FPH - Fisher & Paykel Healthcare News Story

NZD33.3 -0.5  -1.5%

Last Trade - 5:59am

Large Cap
Market Cap £10.03bn
Enterprise Value £10.01bn
Revenue £825.8m
Position in Universe 31st / 1911

BUZZ-Citi says Australian healthcare firms in the pink ahead of earnings

Mon 13th July, 2020 12:56am
** Research broker Citi says Australian healthcare companies
will see earnings declines more at the margin, with only
short-lived disruption, unlike most other sectors
    ** Adds overall the balance sheets of the healthcare sector
are in a strong position and it does not expect further equity
    ** Citi's top picks are CSL Ltd  CSL.AX  and Sonic
Healthcare Ltd  SHL.AX  in large caps, Integral Diagnostics
 IDX.AX  and EBOS Group  EBO.NZ   EBO.AX  in small caps
    ** Maintains "sell" rating on Fisher & Paykel  FPH.NZ 
 FPH.AX  and Nanosonics Ltd  NAN.AX  on valuation
    ** Says key focus issues for the market in the reporting
season for CSL will be plasma collection levels, for Sonic
offshore pathology volumes and for Cochlear Ltd  COH.AX 
surgical volumes in the United States and Europe
    ** Says the key question for Ansell Ltd  ANN.AX  will be
whether personal protection increase has offset industrial
production volume declines
    ** Adds FY21 earnings remain difficult to predict and are
largely dependent on the opening of economies from COVID-19

 (Reporting by Shruti Sonal in Bengaluru)
 ((; Twitter: @shrutisonal26))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.